Does Your Walking Pace Matter as Much as Your Minutes for Blood Pressure?

Once walking becomes part of a blood-pressure plan, an ordinary activity can start to feel surprisingly numerical. Ten minutes or thirty? Every day or a few times a week? A step target or a stopwatch? The appeal of one exact number is obvious. Before choosing it, it helps to ask what the number is meant to represent.

A useful starting point comes from general physical-activity guidance rather than a blood-pressure-specific walking prescription. The World Health Organization recommends that adults accumulate 150–300 minutes of moderate-intensity aerobic activity each week, or an equivalent amount of vigorous activity. Walking can contribute to that total when the intensity is high enough. If walking is the main activity, the lower end of the recommendation can be pictured as roughly 30 minutes on five days of the week, but that is a convenient way to divide a weekly target, not a physiological cutoff.¹

Walking itself has been tested against resting blood pressure in randomized trials. A 2022 meta-analysis drawing on 73 trials and up to 5,060 participants found that walking reduced systolic blood pressure by an average of about 3.9 mmHg compared with control conditions. Diastolic pressure fell by about 1.4 mmHg across 69 trials involving 4,711 participants. The studies included adults with both normal and elevated blood pressure, so these are group averages rather than a prediction of how much any one person’s blood pressure will change.²

More recent research has tried to answer a narrower question: how much brisk walking may be most useful for people who already have hypertension. A 2026 systematic review and Bayesian meta-analysis included 17 randomized trials with 1,493 participants. Overall, brisk walking produced moderate standardized reductions in both systolic and diastolic blood pressure. In the dose-response models, the largest estimated systolic reduction occurred around 460 MET-minutes per week, while the largest estimated diastolic reduction was around 620 MET-minutes per week.³

Those numbers look precise, but they should not be read as precise prescriptions. The authors judged the certainty of the dose-response evidence to be low, and the included studies differed substantially. They translated the modeled exposure into roughly 150–210 minutes of moderate-intensity brisk walking per week, but MET-minutes combine both intensity and duration, so the same MET-minute dose does not always correspond to the same number of walking minutes. The findings are better treated as an approximate reference than as evidence that 149 minutes is insufficient or that benefits peak at one universal number.³

Duration of the program deserves similar caution. Longer interventions, particularly those extending beyond 12 weeks, tended to show larger reductions in subgroup analyses. That does not establish 12 weeks as a biological threshold; it suggests that a repeated walking habit matters more than treating a particular duration as a deadline.³

Intensity belongs in the calculation too. The trial evidence cited here largely concerns moderate or brisk walking, not simply accumulating the same number of minutes at any pace. What counts as a moderate effort can differ with fitness, age, terrain, and walking speed, which is another reason a fixed number of minutes cannot describe the entire exercise dose.^1,3

Walking also sits inside a broader blood-pressure strategy. WHO lists regular physical activity alongside measures such as a healthy diet and weight management for people with hypertension, while noting that many people still need antihypertensive medication. Walking can contribute meaningfully to blood-pressure management, but a walking target is not a substitute for prescribed treatment.⁴

A walking plan should not become another perfect number to chase. The useful next question is what a repeatable routine could look like in an ordinary week.